SSShu Su

Shu Su

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shu Su has a total of 104 co-authors. Here are the top co-authors by number of shared publications:

  • Lei Zhang

    Northwestern Polytechnical University, Xi'an, China

    10 shared publications
  • Bingyang She

    China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi 710061, China

    5 shared publications
  • Fang Lu

    China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi 710061, China

    5 shared publications
  • Yi Liu

    Phase I Clinical Trial Research Ward, The Second Affiliated Hospital of Xi'an Jiaotong University, No. 157 Xi Wu Road, Xi'an, Shaanxi 710004, China; China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi 710061, China

    5 shared publications
  • Gaixia Li

    China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi 710061, China

    4 shared publications
  • Rui Zhao

    4 shared publications

Latest Publications

  • Towards patient-centered HIV drug resistance testing services in China: A discrete choice experiment

    by Qingxian Song, Qianqian Shen, Tengxiao Long, Yingni Yu, Shu Su

    Background: HIV drug resistance testing plays an important role in optimizing antiretroviral therapy, yet routine testing remains limited in China. This study applied a discrete choice experiment to evaluate patient preferences and willingness-to-pay for HIV drug resistance testing; to inform patient-centered implementation strategies for HIV drug resistance testing. Methods: Between April and June 2025, people living with HIV were recruited from community healthcare centers in China. Mixed logit models and latent class analysis were used to quantify attribute trade-offs, identify preference heterogeneity, and estimate willingness-to-pay across clinical and demographic subgroups. Results: Among 204 participants, out-of-pocket cost was the dominant barrier to uptake, accounting for 62.3% of overall decision importance. Testing after treatment failure ( β = 0.862), and doctor recommendation ( β = 0.519) were primary determinants of choice (all p < 0.001). Combined testing ( p = 0.037), shorter waiting time (3 days: p = 0.008), and high accuracy ( p = 0.031) also significantly increased testing preference. Latent class analysis identified two distinct subgroups. Class 1 (failure-driven) prioritized testing after treatment failure ( β = 3.547) but showed a negative preference for combined testing and high accuracy (all p < 0.05). Class 2 (service-oriented) strongly valued doctor recommendation and high accuracy (all p < 0.01). Older participants (≥50 years old) had a higher willingness-to-pay for doctor recommendation than the younger (240.2 vs 115.7 CNY), while younger showed higher WTP for combined testing and high accuracy. Conclusions: Reducing financial barriers, strengthening provider recommendations, and tailoring testing services to different patient preference patterns may improve HIV drug resistance testing uptake. These findings support patient-centered implementation strategies to promote earlier and more routine HIV drug resistance testing in China.

  • Open Access

    Longitudinal Patterns of Within- and Cross-Domain Multimorbidity Across Physical, Psychological, and Cognitive Conditions in China and the United States: The Role of Socioeconomic and Healthcare Inequalities

    by Meng Jia, Yingni Yu, Shu Su

    Background: Multimorbidity is a growing global health challenge in aging populations, yet its progression across physical, psychological, and cognitive domains and its contribution to health inequalities remain unclear. We compared longitudinal patterns of multimorbidity in China and the United States (US) and examined the socioeconomic and healthcare-related factors associated with these patterns and their functional consequences. Methods: This longitudinal cohort study included adults aged ≥45 years from China (2011–2020) and the US (2012–2020), matched 1:1 by baseline age and sex. Multimorbidity was classified into eight domains spanning physical, psychological, and cognitive conditions and their combinations. Longitudinal changes across five survey waves were assessed. Multinomial logistic mixed models examined socioeconomic and healthcare-related correlations, and Cox models estimated associations with subsequent limitations in activities of daily living (ADL) limitations and instrumental activities of daily living (IADL) limitations. Results: A total of 7064 participants from China (mean age 60.15 ± 7.93 years; 45.4% male) and 7064 matched participants from the US were included. Multimorbidity patterns were more complex in the US at baseline, but progression toward cross-domain multimorbidity occurred in both countries and was more pronounced in China. Psychological conditions occupied a central position in the development of more complex multimorbidity patterns. Higher educational and household wealth were consistently associated with lower odds of cognitive-related and cross-domain multimorbidity in both countries, whereas associations with healthcare-related factors varied across settings. Cross-domain multimorbidity was more strongly associated with functional limitations than within-domain multimorbidity. In particular, physical–psychological–cognitive multimorbidity was associated with substantially higher risks of ADL limitations (hazard ratio (HR) = 5.70, 95% confidence interval (CI) = 4.87–6.67 in China; HR = 7.72, 95% CI = 5.90–10.11 in the US) and IADL limitations (HR = 4.14, 95% CI = 3.64–4.71; HR = 5.84, 95% CI = 4.50–7.59, respectively). Conclusions: Multimorbidity increasingly spans physical, psychological, and cognitive domains in both China and the US. Psychological conditions appeared to bridge physical and cognitive conditions in more complex multimorbidity patterns. Integrated care models incorporating psychological health and strategies addressing socioeconomic inequalities may help reduce the burden of multimorbidity and related functional decline.

  • Open Access

    Global Trends and Disparities in HIV Pre-Exposure Prophylaxis Acceptance Among Key Populations: A Systematic Review and Meta-Analysis

    by Min Zhao, Zhengcheng Tu, Rui Zhao, Yufei Gu, Haoyang Liu, Yudong Wei, Shu Su, Jason J. Ong, Fanpu Ji, Lei Zhang

    Background: The UNAIDS target of 21·2 million pre-exposure prophylaxis (PrEP) users by 2025 remains unmet. We aimed to estimate acceptance of oral and injectable PrEP among key populations and examine population-specific, economic, geographical, and temporal disparities.Methods: We searched PubMed, Embase, and Web of Science from database inception to March 31, 2026, for studies reporting quantitative data on PrEP acceptance, willingness, intention, or attitude among populations at increased HIV risk. Eligible populations included gay, bisexual, and other men who have sex with men (GBM), transgender people, serodiscordant couples, sex workers, people who use drugs, adolescents and students, adult women, and other high-burden populations. Pooled acceptance was estimated with random-effects meta-analysis. Temporal trends were assessed using linear regression, and multilevel mixed-effects models were fitted to logit-transformed oral PrEP acceptance.Findings: We included 531 studies. Oral PrEP acceptance was reported in 496 studies from 67 countries or territories, and injectable PrEP acceptance in 70 studies from 39 countries or territories. Pooled acceptance was 60·6% (95% CI 58·7–62·5; I²=99·5%) for oral PrEP and 62·0% (56·4–67·4; I²=99·7%) for injectable PrEP. Oral PrEP acceptance was highest among male sex workers (84·1%, 65·8–96·4) but lowest among adult women (51·7%, 44·3–59·1). Injectable PrEP acceptance was highest among female sex workers (78·3%, 71·2–84·6) and adult women (69·0%, 56·6–80·2). In adjusted analyses, adult women had lower odds of oral PrEP acceptance than GBM (aOR=0·49, 95% CI 0·36–0·67). Oral PrEP acceptance was higher in lower-income settings than in other income settings. Oral PrEP acceptance did not increase overall, except among GBM, mainly in the Americas.Interpretation: Oral PrEP acceptance among key populations is moderate and varies substantially across populations, regions, and income levels. Injectable PrEP showed acceptance comparable to oral PrEP, although evidence remains limited. Scale-up should prioritise context-specific strategies that translate willingness into uptake, persistence, and effective protection.

  • Open Access

    Dynamic AFP-Defined Disease State Transitions in Hospitalized Patients with Hepatocellular Carcinoma Using the Multi-State Markov Model: A Retrospective Cohort Study

    by Qingxian Song, Huiyi Zhang, Meng Jia, Yingni Yu, Ying Jiang, Jun Yuan, Shu Su

    Background: Hepatocellular carcinoma (HCC) exhibits highly variable disease trajectories, posing challenges for longitudinal monitoring and prognostic assessment. Alpha-fetoprotein (AFP) is widely used in HCC management, but transitions between discrete AFP states over time have not been explicitly modeled. Methods: We conducted a retrospective cohort study of 2,750 hospitalized HCC patients between 2016 and 2024, encompassing 17,076 hospitalizations. AFP measurements were categorized into four clinical relevant states (S1–S4, from low to high). A multi-state Markov (MSM) model was constructed to estimate transition probabilities, transition rates, and sojourn times, and to assess the effects of hepatitis B virus (HBV) infection, antiviral therapy, and major clinical covariates. Longitudinal AFP transitions were visualized using Sankey diagrams. Results: Among 2,750 hospitalized HCC patients, AFP-defined disease states S1 and S4 were relatively stable, whereas intermediate states S2 and S3 exhibited frequent bidirectional transitions. Tenofovir disoproxil fumarate (TDF) therapy was associated with S2→S1 AFP decrease (HR 1.350, 95% CI 1.065– 1.710). Elevated alanine aminotransferase (ALT) showed bidirectional effects (S1→S2: HR 1.310, 95% CI 1.011– 1.696; S3→S4: HR 1.517, 95% CI 1.130– 2.035; S2→S1: HR 1.493, 95% CI 1.191– 1.872; S3→S2: HR 1.685, 95% CI 1.295– 2.193; S4→S3: HR 1.527, 95% CI 1.153– 2.021), while elevated aspartate aminotransferase (AST), and total bilirubin (TBIL) were associated with lower likelihood of AFP decrease (AST S4→S3: HR 0.664, 95% CI 0.486– 0.908; TBIL S3→S2: HR 0.687, 95% CI 0.492– 0.958; S4→S3: HR 0.674, 95% CI 0.472– 0.965). Shorter sojourn times and higher hospitalization frequencies indicated clinical instability in intermediate disease states, suggesting a potentially modifiable window for clinical intervention. Conclusion: This study characterizes dynamic AFP-defined disease state transitions in hospitalized patients with HCC. Intermediate disease states represent unstable but potentially modifiable phases strongly influenced by antiviral therapy and liver function status. These findings support the value of longitudinal AFP monitoring beyond single time-point assessment and individualized clinical management.

  • Open Access

    Network dynamics of metabolic disease continuum in older adults: a 7-year longitudinal cohort study in China

    by Guoqing Xu, Qingxian Song, Meng Jia, Yingni Yu, Shu Su, Jinning Mao

    Metabolic diseases co-occur as multimorbidity rather than presenting in isolation. This study aims to estimate the evolution and patterns of multimorbidity


  • Open Access

    Balancing strategies in vaccination and mask-wearing for Chinese medical staff in post-COVID-19 era: a modelling study and cost-effectiveness analysis

    by Yiyu Hu, Meng Jia, Ying Jiang, Rui Zhao, Shu Su

    The emergence of the COVID-19 has prompted a global effort to defend against the virus [1]. From 2019 to 2022, the coronavirus has continuously mutated, resulting in diverse impacts on various regions. Given its varying degrees of severity and transmission, from the original virus to Omicron [2], China undertook decisive measures in December 2022, lifting […]


  • Open Access

    Clustering analysis of sexual behavioral patterns and risk of sexually transmitted infections in Chinese men who have sex with men

    by Bingyang She, Yiming Liu, Siqi Lin, Fang Lu, Yi Liu, Jiajun Sun, Gaixia Li, Yawu Hu, Shu Su, Lei Zhang